Patents Assigned to Marinus Pharmaceuticals
  • GANAXOLONE FORMULATION AND USE THEREOF
    Publication number: 20190117673
    Abstract: In certain embodiments, the invention is directed to composition comprising stable particles comprising ganaxolone, wherein the volume weighted median diameter (D50) of the particles is from about 50 nm to about 500 nm.
    Type: Application
    Filed: October 2, 2018
    Publication date: April 25, 2019
    Applicant: Marinus Pharmaceuticals
    Inventors: Kenneth Shaw, Mingbao Zhang
  • SOLID GANAXOLONE COMPOSITIONS AND METHODS FOR THE MAKING AND USE THEREOF
    Publication number: 20170202855
    Abstract: In certain embodiments, the invention is directed to composition comprising stable particles comprising ganaxolone, wherein the volume weighted median diameter (D50) of the particles is from about 50 nm to about 500 nm.
    Type: Application
    Filed: September 26, 2016
    Publication date: July 20, 2017
    Applicant: Marinus Pharmaceuticals
    Inventors: Kenneth SHAW, Mingbao ZHANG
  • Solid ganaxolone compositions and methods for the making and use thereof
    Patent number: 9452176
    Abstract: In certain embodiments, the invention is directed to composition comprising stable particles comprising ganaxolone, wherein the volume weighted median diameter (D50) of the particles is from about 50 nm to about 500 nm.
    Type: Grant
    Filed: May 11, 2015
    Date of Patent: September 27, 2016
    Assignee: Marinus Pharmaceuticals
    Inventors: Kenneth Shaw, Mingbao Zhang
  • Liquid ganaxolone formulations and methods for the making and use thereof
    Patent number: 9056116
    Abstract: In certain embodiments, the invention is directed to composition comprising stable particles comprising ganaxolone, wherein the volume weighted median diameter (D50) of the particles is from about 50 nm to about 500 nm.
    Type: Grant
    Filed: October 22, 2012
    Date of Patent: June 16, 2015
    Assignee: Marinus Pharmaceuticals
    Inventors: Kenneth Shaw, Mingbao Zhang
  • Solid ganaxolone compositions and methods for the making and use thereof
    Patent number: 9029355
    Abstract: In certain embodiments, the invention is directed to composition comprising stable particles comprising ganaxolone, wherein the volume weighted median diameter (D50) of the particles is from about 50 nm to about 500 nm.
    Type: Grant
    Filed: November 22, 2013
    Date of Patent: May 12, 2015
    Assignee: Marinus Pharmaceuticals
    Inventors: Kenneth Shaw, Mingbao Zhang
  • Stable corticosteroid nanoparticulate formulations and methods for the making and use thereof
    Patent number: 9017728
    Abstract: Disclosed are stable corticosteroid nanoparticulate formulations, methods of making and therapeutic uses thereof.
    Type: Grant
    Filed: May 6, 2013
    Date of Patent: April 28, 2015
    Assignee: Marinus Pharmaceuticals
    Inventors: Kenneth Shaw, Mingbao Zhang
  • SOLID GANAXOLONE COMPOSITIONS AND METHODS FOR THE MAKING AND USE THEREOF
    Publication number: 20140154309
    Abstract: In certain embodiments, the invention is directed to composition comprising stable particles comprising ganaxolone, wherein the volume weighted median diameter (D50) of the particles is from about 50 nm to about 500 nm.
    Type: Application
    Filed: November 22, 2013
    Publication date: June 5, 2014
    Applicant: Marinus Pharmaceuticals
    Inventors: Kenneth Shaw, Mingbao Zhang
  • Solid ganaxolone formulations and methods for the making and use thereof
    Patent number: 8618087
    Abstract: In certain embodiments, the invention is directed to composition comprising stable particles comprising ganaxolone, wherein the volume weighted median diameter (D50) of the particles is from about 50 nm to about 500 nm.
    Type: Grant
    Filed: December 19, 2012
    Date of Patent: December 31, 2013
    Assignee: Marinus Pharmaceuticals
    Inventors: Kenneth Shaw, Mingbao Zhang
  • Stable Corticosteroid Nanoparticulate Formulations and Methods for the Making and Use thereof
    Publication number: 20130243830
    Abstract: Disclosed are stable corticosteroid nanoparticulate formulations, methods of making and therapeutic uses thereof.
    Type: Application
    Filed: May 6, 2013
    Publication date: September 19, 2013
    Applicant: Marinus Pharmaceuticals
    Inventors: Kenneth Shaw, Mingbao Zhang
  • SOLID GANAXOLONE FORMULATIONS AND METHODS FOR THE MAKING AND USE THEREOF
    Publication number: 20130156821
    Abstract: In certain embodiments, the invention is directed to composition comprising stable particles comprising ganaxolone, wherein the volume weighted median diameter (D50) of the particles is from about 50 nm to about 500 nm.
    Type: Application
    Filed: December 19, 2012
    Publication date: June 20, 2013
    Applicant: Marinus Pharmaceuticals
    Inventors: Marinus Pharmaceuticals, Chris Cashman
  • Stable corticosteroid nanoparticulate formulations and methods for the making and use thereof
    Patent number: 8455002
    Abstract: Disclosed are stable corticosteroid nanoparticulate formulations, methods of making and therapeutic uses thereof.
    Type: Grant
    Filed: May 11, 2010
    Date of Patent: June 4, 2013
    Assignee: Marinus Pharmaceuticals
    Inventors: Kenneth Shaw, Mingbao Zhang
  • Solid ganaxolone formulations and methods for the making and use thereof
    Patent number: 8367651
    Abstract: In certain embodiments, the invention is directed to composition comprising stable particles comprising ganaxolone, wherein the volume weighted median diameter (D50) of the particles is from about 50 nm to about 500 nm.
    Type: Grant
    Filed: March 21, 2011
    Date of Patent: February 5, 2013
    Assignee: Marinus Pharmaceuticals
    Inventors: Kenneth Shaw, Mingbao Zhang
  • Liquid ganaxolone formulations and methods for the making and use thereof
    Patent number: 8318714
    Abstract: In certain embodiments, the invention is directed to composition comprising stable particles comprising ganaxolone, wherein the volume weighted median diameter (D50) of the particles is from about 50 nm to about 500 nm.
    Type: Grant
    Filed: August 25, 2011
    Date of Patent: November 27, 2012
    Assignee: Marinus Pharmaceuticals
    Inventors: Kenneth Shaw, Mingbao Zhang
  • LIQUID GANAXOLONE FORMULATIONS AND METHODS FOR THE MAKING AND USE THEREOF
    Publication number: 20120052098
    Abstract: In certain embodiments, the invention is directed to composition comprising stable particles comprising ganaxolone, wherein the volume weighted median diameter (D50) of the particles is from about 50 nm to about 500 nm.
    Type: Application
    Filed: August 25, 2011
    Publication date: March 1, 2012
    Applicant: Marinus Pharmaceuticals
    Inventors: Kenneth SHAW, Mingbao Zhang
  • SOLID GANAXOLONE FORMULATIONS AND METHODS FOR THE MAKING AND USE THEREOF
    Publication number: 20110236487
    Abstract: In certain embodiments, the invention is directed to composition comprising stable particles comprising ganaxolone, wherein the volume weighted median diameter (D50) of the particles is from about 50 nm to about 500 nm.
    Type: Application
    Filed: March 21, 2011
    Publication date: September 29, 2011
    Applicant: Marinus Pharmaceuticals
    Inventors: Kenneth SHAW, Mingbao Zhang
  • Liquid ganaxolone formulations and methods for the making and use thereof
    Patent number: 8022054
    Abstract: In certain embodiments, the invention is directed to composition comprising stable particles comprising ganaxolone, wherein the volume weighted median diameter (D50) of the particles is from about 50 nm to about 500 nm.
    Type: Grant
    Filed: November 28, 2006
    Date of Patent: September 20, 2011
    Assignee: Marinus Pharmaceuticals
    Inventors: Kenneth Shaw, Mingbao Zhang
  • Stable Corticosteroid Nanoparticulate Formulations And Methods For The Making And Use Thereof
    Publication number: 20110008453
    Abstract: Disclosed are stable corticosteroid nanoparticulate formulations, methods of making and therapeutic uses thereof.
    Type: Application
    Filed: May 11, 2010
    Publication date: January 13, 2011
    Applicant: Marinus Pharmaceuticals
    Inventors: Kenneth Shaw, Mingbao Zhang
  • Solid ganaxolone formulations and methods for the making and use thereof
    Patent number: 7858609
    Abstract: In certain embodiments, the invention is directed to composition comprising stable particles comprising ganaxolone, wherein the volume weighted median diameter (D50) of the particles is from about 50 nm to about 500 nm.
    Type: Grant
    Filed: November 28, 2006
    Date of Patent: December 28, 2010
    Assignee: Marinus Pharmaceuticals
    Inventors: Kenneth Shaw, Mingbao Zhang
  • Nanoparticulate formulations and methods for the making and use therof
    Publication number: 20090004262
    Abstract: The present invention is directed to size-stabilized drug nanoparticulate compositions and methods of preparation thereof.
    Type: Application
    Filed: November 28, 2007
    Publication date: January 1, 2009
    Applicant: Marinus Pharmaceuticals
    Inventors: Kenneth Shaw, Mingbao Zhang
  • Solid ganaxolone formulations and methods for the making and use thereof
    Publication number: 20070148252
    Abstract: In certain embodiments, the invention is directed to composition comprising stable particles comprising ganaxolone, wherein the volume weighted median diameter (D50) of the particles is from about 50 nm to about 500 nm.
    Type: Application
    Filed: November 28, 2006
    Publication date: June 28, 2007
    Applicant: Marinus Pharmaceuticals
    Inventors: Kenneth Shaw, Mingbao Zhang